
Cost to bring large cap biopharmaceutical assets to market 2010-2020
This statistic shows the cost for large cap biopharma companies to bring an asset to market from 2010 to 2020. According to the data, in 2020, the cost to bring an asset to market was almost 2.5 billion U.S. dollars.